Brief: Ampio Pharmaceuticals Updates Regulatory Status For Ampion

Ampio Pharmaceuticals

13/12/2018 11:09

Dec 13 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO UPDATES REGULATORY STATUS FOR AMPION
    * AMPIO PHARMACEUTICALS INC -  A TRIAL OF ABOUT 150 KL4
PATIENTS
HAS BEEN DESIGNED, WILL BE FILING SPA SUBMISSION IN NEAR FUTURE
    * AMPIO PHARMACEUTICALS - FDA OFFICE OF TISSUE & ADVANCED
THERAPIES ON DEC. 12 PROVIDED FINAL GUIDANCE TO CO ON CLINICAL
PATHWAY OF AMPION
    * AMPIO - FDA'S OTAT SAYS CO SHOULD COMPLETE ADDITIONAL
TRIAL OF
KL4 OSTEOARTHRITIS PATIENTS WITH CONCURRENT CONTROLS DONE UNDER
A SPECIAL PROTOCOL ASSESSMENT

Source text for Eikon:  ID:nPn3VkZB7a 
Further company coverage:  AMPE.A 

 ((Reuters.Briefs@thomsonreuters.com;))